© 2020 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Activity update on therapeutics
The increased activity in ophthalmic research is reflected in the long list of clinical studies in their various stages: nearly 300 studies of various aspects of glaucoma and close to 250 studies on ocular surface, cornea and dry eye.
"The increased activity in ophthalmic research is reflected in the long list of clinical studies in their various stages: nearly 300 studies of various aspects of glaucoma and close to 250 studies on ocular surface, cornea and dry eye. Searching the web for retina clinical studies yields about 250 studies, about 190 studies are listed for macular edema and approximately 70 studies for AMD. This clinical bustle heralds the changes that we will soon see in the practice of ophthalmology," so says Sara Krupsky, one of the organiers of the 8th Symposium on Ocular Pharmacology and Therapeutics (ISOPT) in Rome 3–6 December.
"The landscape of ocular therapeutics cannot be fully portrayed without bringing up innovations in ocular drug delivery such as slow release devices implanted in the eye. ISOPT 2009 will accordingly bring to focus the latest novelties in medical devices," continued Dr Krupsky.
The ISOPT programme is geared to provide a continuum, spreading from basic development of therapeutic concepts to their utilization as drugs and technologies in clinical reality. Considerations common to drug development will be discussed with researchers based in academia, clinical investigators, regulatory affairs and industry professionals.